from the United States Court of Appeals for the Second Circuit
See other cases from the Second Circuit.
Petition DENIED.
Motion for leave to file amicus brief filed by National Minority Quality Forum GRANTED.
Reply of petitioner Pfizer Inc. filed. (Distributed)
Waiver of the 14-day waiting period for the distribution of the petition pursuant to Rule 15.5 filed by petitioner.
Brief of respondents United States Department of Health and Human Services, et al. in opposition filed.
Brief amici curiae of Johnson & Johnson Patient Assistance Foundation, Inc. and Janssen Pharmaceuticals, Inc. filed.
Motion for leave to file amicus brief filed by National Minority Quality Forum.
Brief amicus curiae of Pharmaceutical Research and Manufacturers of America filed.
Brief amicus curiae of TrialCard Inc. filed.
Motion to extend the time to file a response is granted and the time is extended to and including December 14, 2022.
Motion to extend the time to file a response from November 14, 2022 to December 14, 2022, submitted to The Clerk.
Petition for a writ of certiorari filed. (Response due November 14, 2022)
Pfizer Inc., Petitioner, represented by Douglas Harry Hallward-Driemeier
United States Department of Health and Human Services, et al., Respondent, represented by Elizabeth B. Prelogar
Johnson & Johnson Patient Assistance Foundation, Inc.; Janssen Pharmaceuticals, Inc., Amicus Curiae, represented by Paul J. Zidlicky
National Minority Quality Forum, Amicus Curiae, represented by Kelly Patrick Dunbar
Pharmaceutical Research and Manufacturers of America, Amicus Curiae, represented by Jeffrey S. Bucholtz
TrialCard Inc., Amicus Curiae, represented by Carter G. Phillips